7 completed, 1 terminated, 1 withdrawn. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 7, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow 3M: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Patient Preoperative Preps In-vivo CHG/IPA Surgical skin preparation, Normal saline - Surgical Skin Preparation | Phase 3 | Completed | Solventum US LLC | 154 | 2020-07-06 | 2024-10-01 |
| Negative Pressure Wound Therapy in Post-Operative Incision Management dry gauze, The Prevena Incision Management System - Negative-Pressure Wound Therapy | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 583 | 2016-02-01 | 2025-03-18 |
| In Vivo Efficacy Study of Patient Preoperative Preps 3M CHG/IPA Prep C, 3M CHG/IPA Prep CH, ChloraPrep - Bacterial Reduction Post-product Application | Phase 3 | Completed | 3M | 738 | 2014-07-01 | 2020-11-23 |
| In-vivo Efficacy Study of Patient Pre-operative Preps ChloraPrep Hi-Lite Orange, Normal saline, 3M CHG/IPA Prep Tint 10.5-mL - Bacterial Reduction on Skin Flora Post-product Application | Phase 3 | Completed | Solventum US LLC | 426 | 2013-10-01 | 2024-10-02 |
| In-vivo Efficacy Study of Patient Preoperative Preps 3M CHG/IPA Prep Colorless, 3M CHG/IPA Prep Tint, ChloraPrep - Skin Flora Bacterial Reduction Post-product Application | Phase 3 | Terminated | Solventum US LLC | 171 | 2013-10-01 | 2024-10-02 |
| Clinical Performance of a Chlorhexidine Antimicrobial Dressing Chlorhexidine gluconate, Transparent Adhesive Dressing - Catheterization | Phase 2 / Phase 3 | Completed | Solventum US LLC | 68 | 2007-10-01 | 2024-10-24 |
| Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study imiquimod 5% cream (Aldara) - Morphea | Phase 3 | Withdrawn | University of Alberta | 2005-11-01 | 2015-04-23 | |
| Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses imiquimod - Actinic Keratoses | Phase 3 | Completed | University of British Columbia | 20 | 2005-02-01 | 2006-05-09 |
| Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream Cavilon (TM) Durable Barrier Cream, Sorbolene, Radiotherapy - Breast Cancer | Phase 3 | Completed | Trans Tasman Radiation Oncology Group | 333 | 2004-03-01 | 2009-05-14 |
Breast Neoplasms (1) · Carcinoma, Squamous Cell (1) · Keratosis, Actinic (1) · Precancerous Conditions (1) · Scleroderma, Localized (1)
Saline Solution (4) · Sodium Chloride (4) · chlorhexidine gluconate (4) · 2-Propanol (3) · Chromogranins (3) · Ethanol (3) · Imiquimod (2) · DAT protocol 1 (1) · Radiotherapy (1)
United States (5) · Canada (2) · Australia (1)
Muhammad H Bashir, MD, CCRP (2) · Jamie Miller, ADN (1) · Jason K Rivers, M.D. (1) · Mario Leitao, MD (1) · Mark E Rupp, M.D. (1) · Marlene T Dytoc, MD PhD (1) · Peter Graham (1) · Robert R McCormack, BS (1)